[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/pages/docs/Risk/index.md) >> Individual ID:PBN__Risk_16435 

# __Risk of new variants and mutations__

## Articles mentionning the risk

* [Pilati_digital_2021](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_609.md)

## Mitigations of this risk

* [Continued surveillance, development of variant-specific vaccines, research on immune response](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_18378.md)

## Name of the risk

Potential resistance to existing vaccines, increased transmissibility or severity

## People affected by this risk

* [General population](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_68.md)
* [Healthcare workers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_9.md)
* [Vaccinated individuals](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_1289.md)

## Stakeholders who can mitigate this risk

* [Pharmaceutical companies](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_413.md)
* [Research institutions](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_124.md)

## Technologies linked to the risk

* [Genomic sequencing](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_4871.md)
* [Vaccine research and development](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_4872.md)

## This Risk belongs to this RiskGroup

* [Public health risks](https://github.com/mm80843/T3.5/blob/pages/RiskGroup/PBN__RiskGroup_3.md)

## This Risk belongs to this RiskSubgroup

* [Lack of effective medical solutions](https://github.com/mm80843/T3.5/blob/pages/RiskSubgroup/PBN__RiskSubgroup_37.md)

